United States

People: AfroCentric Investment Corporation Ltd (ACTJ.J)

ACTJ.J on Johannesburg Stock Exchange

22 Jun 2017
Change (% chg)

-8.00 (-1.32%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

O'Sullivan, Patrick 

Mr. Patrick J. O'Sullivan is an Independent Director of Allergan Plc. Mr. O’Sullivan joined the Board of Directors in October 2013. He previously served as a member of Warner Chilcott’s Board of Directors beginning 2009. He retired from LEO Pharma A/S in 2006, after 30 years of service with LEO. Prior to his retirement, Mr. O’Sullivan served in positions of increasing responsibility with LEO, most recently as the Chief Executive Officer of LEO Pharma Ireland and as a director of LEO. He also served as a director of LEO Pharmaceuticals Ltd. UK, LEO Pharma SA France and The LEO Foundation. Mr. O’Sullivan is a registered pharmacist, a member and honorary fellow of the Pharmaceutical Society of Ireland and a Knight of the Order of the Dannebrog. Currently, Mr. O’Sullivan is a pharmaceutical business consultant and serves on the Board of Directors of Amarin Corporation plc, where he is a member of the Audit Committee and chairs the Nominating and Corporate Governance Committee. The Board of Directors concluded that Mr. O’Sullivan should serve on the Board of Directors because of his demonstrated management ability at senior levels within the pharmaceutical industry, his knowledge of the financial, operational and strategic requirements of a successful international business, which he developed as Chief Executive Officer of LEO Pharma Ireland, and his understanding of the fundamentals of the healthcare industry.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 249,700
Long-Term Incentive Plans, USD --
All Other, USD 199,089
Fiscal Year Total, USD 448,789

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --